(Q44117431)

30 November 2017

0 references

1 reference

title

Megestrol acetate: a systematic review usefulness about the weight gain in neoplastic patients with cachexia (English)

1 reference

30 November 2017

1 reference

1 reference

Oscar Juan

2

0 references

author name string

Vicente Ruiz-García

1

1 reference

30 November 2017

Santiago Pérez Hoyos

3

1 reference

30 November 2017

Rosana Peiró

4

1 reference

30 November 2017

Nieves Ramón

5

1 reference

30 November 2017

M Angeles Rosero

6

1 reference

30 November 2017

Miguel Angel García

7

1 reference

30 November 2017

language of work or name

Spanish

0 references

publication date

1 July 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

119

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

166-170

1 reference

On appetite and its loss.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

A review of the drug treatment of cachexia associated with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Clinical management of anorexia and cachexia in patients with advanced cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Megestrol acetate for anorexia and cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Influences on the quality of published drug studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Hyperglycemia induced by megestrol acetate in a patient with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Thrombotic events associated with megestrol acetate in patients with AIDS cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Megestrol acetate plus alpha 2a interferon as second line therapy for postmenopausal patients with advanced breast cancer: results of a multicentric phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Megestrol acetate in cachectic patients with advanced bronchogenic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

A pilot study of megestrol acetate and ibuprofen in the treatment of cachexia in gastrointestinal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Treatment of cancer weight loss in patients with advanced lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Risks and benefits of various therapies for cancer anorexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Phase III Evaluation of 4 Doses of Megestrol Acetate as Therapy for Patients with Cancer Anorexia and/or Cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Effect of megestrol acetate and prepulsid on nutritional improvement in patients with head and neck cancers undergoing radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Nutritional support of the cancer patient: issues and dilemmas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7753%2802%2973352-6

10.1016/S0025-7753(02)73352-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference